跳至主要内容
临床试验/ISRCTN23721272
ISRCTN23721272已完成未知

A randomised, placebo-controlled, double-blind, factorial trial of prednisolone and/or azathioprine in newly diagnosed cases of cryptogenic fibrosing alveolitis (CFA)

Medical Research Council (MRC) (UK)0 个研究点目标入组 0 人开始时间: 2001年5月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Not provided at time of registration

排除标准

  • Not provided at time of registration

研究者

发起方
Medical Research Council (MRC) (UK)

相似试验

已完成
3 期
A placebo-controlled trial to assess the effect of aspirin and fish oil (omega-3 fatty acids) in the prevention of early thrombosis in arterio-venous fistulae in patients with chronic kidney disease requiring haemodialysisEarly thrombosis in arterio-venous fistulae in patients with Stage IV or V chronic kidney disease requiring haemodialysisRenal and Urogenital - Kidney disease
ACTRN12607000569404Australasian Kidney Trials Network657
进行中(未招募)
不适用
A randomized, double-blind, placebo- controlled, flexible dose study to evaluate the effectiveness and safety of pramipexole IR (0.125 – 0.5mg/day) compared to placebo for 6 weeks in children and adolescents (age 6-17 years) who are diagnosed with Tourette’s DisorderTourette's SyndromeMedDRA version: 14.0Level: LLTClassification code 10044127Term: Tourette's syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2008-004460-39-Outside-EU/EEABoehringer Ingelheim Pharmaceuticals, Inc.54
进行中(未招募)
不适用
A randomized, double-blind, placebo-controlled, flexible dose study to evaluate efficacy and safety of Pramipexole IR (0.0625-0.5 mg/day) versus placebo for 6 weeks in children and adolescents (age 6-17 inclusive) diagnosed with Tourette Disorder according to DSM-IV criteria
EUCTR2008-004460-39-DEBoehringer Ingelheim Pharma GmbH & Co. KG54
进行中(未招募)
不适用
A randomised, double-blind, placebo-controlled, four-way crossover, repeat dose study comparing the effect of inhaled fluticasone furoate/GW642444M combination, GW642444M and fluticasone furoate on the allergen-induced asthmatic response in subjects with mild asthma.subjects with mild asthmaMedDRA version: 12.1Level: LLTClassification code 10003553Term: Asthma
EUCTR2010-019465-28-SEGlaxoSmithKline Research & Development Ltd24
已完成
不适用
DSP-2230 Capsaicin and UVB Challenge StudyPeripheral Neuropathic PainSigns and Symptoms
ISRCTN80154838Sunovion Pharmaceuticals Europe Ltd56